Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2007 by Hormozgan University of Medical Sciences. Recruitment status was Not yet recruiting

First Received on February 6, 2007. Last Updated on May 31, 2007 History of Changes

Sponsor:	Hormozgan University of Medical Sciences
Information provided by:	Hormozgan University of Medical Sciences
ClinicalTrials.gov Identifier:	NCT00432588

Purpose

Hypothesis (H0): Labor duration and obstetric complications are not significantly different in the three groups (misoprostol-dinoprostone-oxytocin).

Condition	Intervention	Phase
Preeclampsia Fetal Death Fetal Membranes, Premature Rupture	Drug: misoprostol Drug: dinoprostone	Phase I Phase II

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment

Resource links provided by NLM:

Drug Information available for: Misoprostol Dinoprostone

U.S. FDA Resources

Further study details as provided by Hormozgan University of Medical Sciences:

Eligibility

Genders Eligible for Study:

Female

Criteria

Inclusion Criteria:

Term pregnancy
Singleton
Vertex
Bishop score below 6

Exclusion Criteria:

History of drug reaction
Medical disease
IUGR
Oligohydramnios
Vaginal bleeding
Fetal anomaly
Uterine scar

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00432588

Locations

Iran, Islamic Republic of
Shariaty Maternity Hospital	Not yet recruiting
Tehran, Iran, Islamic Republic of
Contact: Mitra Ahmad Soltani, MD 0098 021 22301004 m_a_sol@yahoo.com

Sponsors and Collaborators

Hormozgan University of Medical Sciences

Investigators

Principal Investigator:	Mitra Ahmad Soltani	Hormozgan University of Medical Sciences
Study Chair:	Minoo Rajaee Lari, Perinatologist - Obs and Gyn	Department of Obs and Gyn - HUMS

More Information

Additional Information:

Related Info This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier:	NCT00432588 History of Changes
Other Study ID Numbers:	Misoprostol vs Dinoprostone
Study First Received:	February 6, 2007
Last Updated:	May 31, 2007
Health Authority:	United States: Food and Drug Administration

Keywords provided by Hormozgan University of Medical Sciences:

IUFD
POSTTERM
ROM

Additional relevant MeSH terms:

Fetal Death
Fetal Membranes, Premature Rupture
Pre-Eclampsia
Rupture
Pregnancy Complications
Death
Pathologic Processes
Obstetric Labor Complications
Hypertension, Pregnancy-Induced
Wounds and Injuries
Dinoprostone

Misoprostol
Oxytocics
Reproductive Control Agents
Physiological Effects of Drugs
Pharmacologic Actions
Therapeutic Uses
Anti-Ulcer Agents
Gastrointestinal Agents
Abortifacient Agents, Nonsteroidal
Abortifacient Agents

ClinicalTrials.gov processed this record on February 09, 2012